| Financial Year |
March 31 2023 |
| Monetary Funds |
348,810,983.68 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,796,077.58 |
| Accounts Receivable |
33,903,802.08 |
| Advances to Suppliers |
14,374,617.84 |
| Other Receivables |
1,985,618.69 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
659,547.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,577,467.10 |
| Total Current Assets |
421,108,114.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
29,533,204.29 |
| Fixed Assetes |
507,312,204.38 |
| Under-construction Projects |
85,781,590.66 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
36,878,255.07 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,028,684.76 |
| Deferred Income Tax Assets |
1,581,522.30 |
| Other Non-Current Assets |
3,346,206.14 |
| Sub-Total of Non-Current Assets |
682,912,603.38 |
| Total Assets |
1,104,020,717.93 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
16,725,263.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,468,714.14 |
| Taxes Payable |
10,813,371.44 |
| Interest Payable |
-- |
| Dividend Payable |
10,394,964.93 |
| Other payables |
12,508,188.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
156,257.90 |
| Sub-Total of Current Liabilities |
49,602,266.00 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
36,160,445.01 |
| Special Payable |
-- |
| Estimatied Liabilities |
38,507,284.27 |
| Deferred Income Tax Liabilities |
15,483,097.34 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
106,499,991.21 |
| Total Liabilities |
156,102,257.21 |
| Paid-In Capital(Or Share Stock) |
264,001,897.00 |
| Capital Surplus |
263,077,732.81 |
| Surplus Reserve |
43,675,915.78 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
345,826,569.38 |
| Minority Stockholder's Interest |
31,336,345.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
916,582,114.97 |
| Owner's Equity（Stockholder's Equity） |
947,918,460.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,104,020,717.93 |
